| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/24/2010 | CN101679501A methods of treating, diagnosing and detecting fgf21-associated disorders |
| 03/24/2010 | CN101679445A Pyrimidinedione derivatives and methods of use thereof |
| 03/24/2010 | CN101679433A Novel adenine compound |
| 03/24/2010 | CN101679417A New 4,8-diphenyl-polyazanaphthalene derivatives |
| 03/24/2010 | CN101679390A Ground crystal of olmesartan medoxomil |
| 03/24/2010 | CN101679367A Therapeutic agent for cerebral infarction |
| 03/24/2010 | CN101679355A benzimidazole cannabinoid agonists |
| 03/24/2010 | CN101679336A Substituted amino-thiourea compounds for combating animal pests |
| 03/24/2010 | CN101679328A Prophylactic or therapeutic agent for age-related macular degeneration |
| 03/24/2010 | CN101679324A 吗啉衍生物 Morpholine derivatives |
| 03/24/2010 | CN101679317A Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid r |
| 03/24/2010 | CN101679309A Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 03/24/2010 | CN101679300A Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
| 03/24/2010 | CN101679273A 1-substituted tetrahydroisoquinoline compound |
| 03/24/2010 | CN101679262A Pyridone compound |
| 03/24/2010 | CN101679248A Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 03/24/2010 | CN101679243A atropisomer of pyrrole derivative |
| 03/24/2010 | CN101678118A Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 03/24/2010 | CN101678071A Prophylactic agent for renal failure |
| 03/24/2010 | CN101678065A Vaccine therapy for choroidal neovascularization |
| 03/24/2010 | CN101678047A Remedy and diagnostic for mitochondrial dysfunction brain disease |
| 03/24/2010 | CN101678043A Composition for promoting ketone compound formation |
| 03/24/2010 | CN101678034A methods for treating neovascular ocular diseases |
| 03/24/2010 | CN101678030A Use of riboflavin in the treatment of hypertension |
| 03/24/2010 | CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 03/24/2010 | CN101678017A Method of treating diabetes |
| 03/24/2010 | CN101678013A piperidine/piperazine derivatives |
| 03/24/2010 | CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 03/24/2010 | CN101676298A 黑皮质素受体配体 Melanocortin receptor ligands |
| 03/24/2010 | CN101676266A Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same |
| 03/24/2010 | CN101675982A Traditional Chinese medicine composition for warming heart yang and reducing phlegm and absorbing clots |
| 03/24/2010 | CN101675972A Blood-enriching tranquillizing traditional Chinese medicine composition |
| 03/24/2010 | CN101675948A Traditional Chinese medicine composition for treating apoplexy |
| 03/24/2010 | CN101675934A New use of saponins X of dipsacus asperoides |
| 03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
| 03/24/2010 | CN101675925A Dimethylaminoethyl ginkgolide B mesylate injection and preparation method thereof |
| 03/24/2010 | CN100595211C Angiopoietin-2 specific binding agents |
| 03/24/2010 | CN100595200C Compound of dehydrogenated cavidine group and application in medication |
| 03/24/2010 | CN100595195C Preparation method and application of isoquinoline componds and salts thereof |
| 03/24/2010 | CN100594936C Method of enhancing absorptions of transmucosal administration formulations |
| 03/24/2010 | CN100594928C Curcuma extract and its prepn process, medicine composition and use |
| 03/24/2010 | CN100594919C Compositions containing an active fraction isolated from lycium barbarum and methods of using the same |
| 03/24/2010 | CN100594916C Plaster for reducing the blood pressure |
| 03/24/2010 | CN100594915C Traditional Chinese medicine extractive for treating cardiovascular diseases and method of preparing the same and uses thereof |
| 03/24/2010 | CN100594914C Medicine for curing coronary heart disease |
| 03/24/2010 | CN100594910C Compound panoxatriol saponin with physiological activity and its preparation and use |
| 03/24/2010 | CN100594909C Therapeutic agent for hemorrhoidal disease |
| 03/24/2010 | CN100594905C Benazepril pharmaceutical compsition and process for its preparation |
| 03/23/2010 | US7683164 Nucleic acid derivatives |
| 03/23/2010 | US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 03/23/2010 | US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide |
| 03/23/2010 | US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 03/23/2010 | US7683037 Myocardial perfusion imaging method |
| 03/23/2010 | US7682623 Pharmaceutical composition for topical application |
| 03/23/2010 | US7682387 Drug-delivery endovascular stent and method for treating restenosis |
| 03/23/2010 | CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof |
| 03/23/2010 | CA2389767C Quinazoline derivatives as vegf inhibitors |
| 03/23/2010 | CA2375374C Induction of pharmacological stress with adenosine receptor agonists |
| 03/23/2010 | CA2356680C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 03/23/2010 | CA2352436C Polymorphs of telmisartan, processes for preparing them and their use in the preparation of a pharmaceutical composition |
| 03/23/2010 | CA2332608C Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
| 03/23/2010 | CA2203655C Tumor necrosis factor-gamma |
| 03/18/2010 | WO2010030983A2 Pyrazole carboxamide inhibitors of factor xa |
| 03/18/2010 | WO2010030976A2 Methods and compositions for inhibiting atherosclerosis and vascular inflammation |
| 03/18/2010 | WO2010030735A2 Stabilized coating for pharmaceutical formulations |
| 03/18/2010 | WO2010030500A1 Aza-benzimidazolone chymase inhibitors |
| 03/18/2010 | WO2010030395A2 Withaferin a analogs and uses thereof |
| 03/18/2010 | WO2010030317A2 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure |
| 03/18/2010 | WO2010029436A2 Novel solid state forms of ranolazine salts |
| 03/18/2010 | WO2010028846A1 Treatment of acute myocardial infarction (ami) using encapsulated cells encoding and secreting glp-1 peptides or analogs thereof |
| 03/18/2010 | WO2010028676A1 Use of a peptide as a therapeutic agent |
| 03/18/2010 | WO2010028675A1 Use of tyrosinase ( 192-200 ) nonapeptide as a therapeutic agent |
| 03/18/2010 | WO2010028674A1 Use of a peptide as a therapeutic agent |
| 03/18/2010 | WO2010028673A1 Use of a peptide as a therapeutic agent |
| 03/18/2010 | WO2010028672A1 Use of a peptide as a therapeutic agent |
| 03/18/2010 | WO2010028671A1 Use of opiorphin as a therapeutic agent |
| 03/18/2010 | WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 03/18/2010 | WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 03/18/2010 | WO2010010257A3 Appetising medicaments for oral administration in solid form for prevention and/or treatment of cardiac insufficiency in animals |
| 03/18/2010 | WO2009130615A3 Use of deuterium oxide as an elastase inhibitor |
| 03/18/2010 | WO2009000909A3 Salts of perindopril |
| 03/18/2010 | US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis |
| 03/18/2010 | US20100069503 Inhibition of mitogen-activated protein kinases in cardiovascular disease |
| 03/18/2010 | US20100069496 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 03/18/2010 | US20100069474 Novel coumarin derivatives as ion channel openers |
| 03/18/2010 | US20100069461 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
| 03/18/2010 | US20100069448 Human protein tyrosine phosphatase inhibitors and methods of use |
| 03/18/2010 | US20100069408 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 03/18/2010 | US20100069403 Methods for preventing or treating cardiac arrhythmia |
| 03/18/2010 | US20100069401 Use of catecholamines and related compounds as anti-angiogenic agents |
| 03/18/2010 | US20100069384 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy |
| 03/18/2010 | US20100069374 Tricyclic benzopyrane compound |
| 03/18/2010 | US20100069367 LXR and FXR Modulators |
| 03/18/2010 | US20100069363 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof |
| 03/18/2010 | US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors |
| 03/18/2010 | US20100069358 Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase |
| 03/18/2010 | US20100069351 Spiro compound and use thereof |
| 03/18/2010 | US20100069349 Novel compounds as cannabinoid receptor ligands |
| 03/18/2010 | US20100069348 Novel compounds as cannabinoid receptor ligands |
| 03/18/2010 | US20100069347 Heterocyclyl-substituted anti-hypercholesterolemic compounds |